Objective: Both epidemiological and experimental evidence suggests a protective effect of dietary ®ber against disease, such as cancer and cardiovascular disease. The effects of ®ber on lipoproteins are modest, indicating that other mechanisms may be involved. As the hemostatic effects of different types of ®ber are poorly known, we compared the effects of wholemeal rye bread and low-®ber wheat bread on factors related to coagulation, ®brinolysis and platelet function. Design: Subjects consumed rye and wheat bread as part of their habitual diet in a cross-over manner for 4 weeks, with a 4 week washout period between the diet periods. Subjects: Forty healthy subjects (18 men, 22 women), aged 43 AE 2 y. Results: Mean daily intake of ®ber during the rye bread period was 31 g for men and 26 g for women, while the respective ®gures for the wheat bread period were 15 g and 12 g. However, no signi®cant differences between the two periods were seen in factor VII coagulant activity (FVIIc), ®brinogen, prothrombin fragments 1 2 (F1 2), tissue plasminogen activator (tPA) plasminogen activator inhibitor 1 (PAI-1) or 2,3,-dinor-thromboxane B 2 . Fibrin degradation products, D-dimers, were slightly lower after the wheat period (P 0.046).
Introduction
Several prospective studies have reported an inverse association between total ®ber intake and coronary heart disease (CHD) (Kromhout et al, 1982; Kushi et al, 1985; Khaw & Barrett-Connor, 1987; Fehily et al, 1982 , Humble et al, 1993 Rimm et al, 1996; Pietinen et al, 1996) . Even a modest increase in ®ber intake has been associated with reduced risk: increase from a low mean intake of 12 to 18 gaday was associated with a 25% reduction in IHD mortality (Khaw & Barrett-Connor, 1987) . In another study the risk of coronary death was 17% lower when daily intake of ®ber was 10 g higher (Pietinen et al, 1996) . Epidemiological studies possess, however, various problems associated with limitations of diet assessment methods, validity of ®ber measurements and complexity of measuring the independent impact of ®ber due to associations between nutrients. High dietary ®ber intake is, for example, often associated with a low intake of fat, thus being merely an indicator of a healthier lifestyle. Controlled studies are therefore needed for more de®nitive answers on the effects of different types and amounts of ®ber.
Mechanisms for ®ber are thus far unclear. In several of the epidemiological studies the effect of ®ber on lipoproteins has been rather modest and could not account for the substantial effect on risk reduction Pietinen et al, 1996) . Other possible pathways suggested include effects on postprandial lipid response, glucose tolerance, blood pressure and hemostatic factors.
The most important contributors to ®ber intake by the Finns are cereals, particularly rye products. Rye bread comprises approximately 35% of the total cereal intake and 40% of ®ber intake (the 1997 Dietary Survey of Finnish Adults, 1998). Typical rye bread is made from wholegrain rye¯our and is thus high in dietary ®ber (DF 15 ± 17%). Since cereal ®ber, in particular, has been proposed to be related to decreased risk of CHD (Morris et al, 1977; Pietinen et al, 1996; Rimm et al, 1996) , and the effects of different types of cereal ®ber on hemostasis are largely unknown, in this study we wanted to compare the effects of wholemeal rye and low-®ber wheat breads on various factors related to coagulation, ®brinolysis and platelet function in healthy subjects.
Subjects and methods

Subjects
Altogether 43 healthy adults (19 men and 24 women), 24 from Helsinki and 19 from Kuopio, were recruited for the study. Three subjects were excluded during the study: one man and one woman because of noncompliance and one woman due to hospitalization. Thus 40 subjects (18 men and 22 women) ®nished the study. Prerequisites for entering the study were serum total cholesterol concentration 5.5 ± 7.5 mmolal, serum triacylglycerol concentration below 2.5 mmolal and body mass index within the range of 20 ± 32 kgam 2 . The subjects were also not allowed to use lipid-lowering medication. Six subjects smoked regularly. The characteristics of the subjects at entry are shown in Table 1 .
Study design
In this crossover study the subjects consumed rye bread and wheat bread for 4 weeks in a random order with a 4-week wash-out period between the bread periods. Blood samples for the analysis of hemostatic parameters were collected at the end of both bread periods. In addition, the subjects in Helsinki (10 men and 13 women) collected three 24-h urine samples for the analysis of 2,3-dinor-thromboxane B 2 at the respective time points as blood samples were taken.
Daily energy intake and the amount of test breads to be consumed during the bread periods was determined by a 4-day food record before the study. The subjects also received instructions to maintain their body weight ( AE1 kg) and lifestyle habits (exercise, alcohol consumption, smoking) unchanged during the study and were asked to avoid use of analgesics. When it was absolutely necessary to use analgesics, the subjects were advised to use a preparation which did not contain acetylsalicylic acid and were given a list of such preparations. The use of medication was asked for in connection with the blood collections, and daily exercise was recorded during the bread periods.
Body weight and blood pressure were measured every 2 weeks. Weight was measured on a digital scale (light clothing, no shoes) and blood pressure from the right arm when the subject was sitting and had rested for 5 min before the measurement. Two consecutive measurements were taken and the mean of these was recorded.
The study was approved by the Ethics Committee of Kuopio University Hospital and each subject gave informed consent before the study.
Diet
The aim of the bread periods was to replace habitually used bread and baked products with rye bread during the rye bread period and with wheat breads during the wheat bread period, and to maintain the habitual diet otherwise unchanged. The test breads were planned to provide 20% of the daily energy intake. In addition to the test breads, the subjects were allowed to eat one portion of sweet pastry or a portion of porridge a day, preferably rye-based during the rye bread period and wheat-based during the wheat bread period. Pasta and rice could be eaten as part of warm dishes in amounts usually eaten by the subject. Use of cholesterollowering foodstuffs (Benecol 1 ) and foods affecting bowel function (plum and plum juice, dried fruits, brans and muesli, various seeds and licorice) were forbidden from the beginning of the baseline period. Diet adherence was controlled by 4-day food diaries including one weekend day. Diaries were kept during the ®nal 2 weeks of the bread periods. Compliance was also checked by daily records of the use of test breads and other cereals.
Four different rye breads and six different wheat breads were eaten during the rye and wheat bread periods, respectively. The subjects were instructed to eat at least four to ®ve portions of breads a day, each portion with the same energy content. The minimum number of portions varied according to the energy intake of each individual and no maximum was set for the amount of bread to be eaten. All test breads were commercial, commonly used breads which were received from two bakeries (Fazer Bakeries Ltd and Vaasan & Vaasan Ltd). Fresh-baked breads were available once a week from the study center.
The subjects were advised by a clinical nutritionist (in Kuopio) or by a nurse guided by the clinical nutritionist (in Helsinki). Four-day food records were calculated using the Micro-Nutrica 1 program (Social Insurance Institution, Helsinki, Finland) and the database of Finnish foods (Rastas et al, 1993) . The nutrient compositions of the test breads were analysed at the VTT Biotechnology and Food Research Laboratory (Espoo, Finland) and these data were used in the calculations of nutrient intake. The energy content of rye breads was 846 ± 1396 kJa100 g and that of wheat breads 1127 ± 1186 kJa100 g. The dietary ®ber content was 8.6 ± 15.2 ga100 g for rye breads and 1.9 ± 2.6 ga100 g for wheat breads.
Blood and urine measurements Samples of venous blood were collected with minimal stasis in the morning after the subjects had fasted overnight and rested for 10 min before blood collection. Alcohol consumption two days before blood collections, exercise from the previous evening and smoking in the morning before blood collection were forbidden.
Fibrinogen, coagulation factor VII (FVIIc), tissue plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), D-dimers and prothrombin fragment 1 2 (F1 2) were measured in the Blood Coagulation Laboratory of the Finnish Red Cross Blood Transfusion Service (Helsinki, Finland). Fibrinogen and FVIIc were measured using an STA Compact analyzer (Diagnostica Stago, France). Fibrinogen was measured using STA-®brinogen reagent (Diagnostica Stago, France) and IL Test TM Calibration Plasma (Instrumentation Laboratory, Italy). The intra-and interassay coef®cients of variation for this method were 2.9% and 2.9%, respectively. FVIIc was analyzed with a onestage clotting method using commercial FVII de®cient plasma (Stago De®cient VII, Diagnostica Stago, France) and thromboplastin from rabbit brain (STA Neoplastine 1 C1 plus, Diagnostica Stago, France) was used. A pooled human plasma sample standardized for Factors II, VII, IX and X (National Institute for Biological Standards and Control) was used as standard. Intra-and interassay coef®-cients of variation for the FVIIc assay were 6.4% and 7.0%, respectively. were measured with chromogenic methods. The intra-and interassay coef®cients of variation were 8.2% and 4.5%, respectively, for the Ddimer assay, 8% and 13%, respectively, for the PAI-1 assay and 4% and 9% for the tPA assay. Prothrombin fragment 1 2 (F1 2) was measured according to the manufacturer with enzyme immunoassay (Enzygnost F1 2 micro, Behring, Germany). All samples of each subject were analyzed in the same run.
The subjects in Helsinki collected three 24 h urine samples at the end of both bread periods using a Japanese aliquot cup (K.K. Izumi Seisakusyo Co. Ltd., Japan). The urine was stored in 10 ml tubes at 720 C. The analysis of 2,3-dinor-TXB 2 was carried out from pooled 3-day samples. After sample puri®cation by the method of Berens et al (1984) the samples were analysed for 2,3-dinor-TXB 2 with enzyme immuno assay (EIA) as previously described (Turpeinen et al, 1998a (Turpeinen et al, ,1998b .
Statistical analysis
In all analyses P-values`0.05 were considered to be statistically signi®cant, and the results are expressed as mean AE s.e.m. Data were analyzed with SPSS for Windows 6.0.1 statistics program (SPSS, Chicago, IL, USA; Norusis, 1993) . Differences between the bread periods were analyzed with the Wilcoxon test.
Results
There were no changes in mean body weight or blood pressure during the study. Exercise did not differ between the bread periods.
Daily intake of macronutrients was similar during both bread periods, excluding the intake of PUFA in women, which was higher during the rye bread period than during the wheat period (the respective mean intakes were 8.6 and 6.3 gaday, P`0.05, Table 2 ). In women, alcohol intake also differed between the bread periods being lower during the rye period (P`0.05). The study subjects consumed the test breads as suggested (minimum four to ®ve portionsa day), and the use of other cereals did not exceed that recommended (one portion a day, Table 3 ). The mean daily intake of ®ber during the rye bread period was 31 g for men and 26 g for women, while the respective ®gures for the wheat bread period were 15 and 12 g ( Table 2 ). The goal for the difference in ®ber intake between rye and wheat periods (15 gaday) was thus achieved by men and also nearly by women. When compared with the wheat Hemostatic factors after rye and wheat bread consumption AM Turpeinen et al bread period the intake of total ®ber was on average 115% higher, that of soluble ®ber 65% higher and that of insoluble ®ber 215% higher during the rye bread period. No signi®cant differences between the diet periods were seen in plasma FVIIc, ®brinogen, F1 2, tPA, PAI-1 or urinary 2,3-dinor-TXB 2 (Table 4) . Also, plasma triglycerides remained unchanged throughout the study. The plasma level of D-dimers, ®brin degradation products, was slightly lower after the wheat period (P 0.046). Smokers (n 6) had higher levels of D-dimers than non-smokers (n 34), but there were no differences in the reponse to the diets between men and women.
When the results were analyzed separately for tertiles of bread intake, no differences in any of the hemostatic factors were seen during the rye bread period. During the wheat bread period tPA was signi®cantly lower in the highest tertile (0.21 vs 0.35 IUaml; P 0.03) when compared with the lowest one. No differences between men and women were seen either after the wheat or rye bread periods.
Discussion
The protective effect of dietary ®ber against CHD has in epidemiological studies been attributed to cereal ®ber, in particular. We compared the effects of two sources of cereal ®ber, namely wheat bread and rye bread, differing in both the amount and type of ®ber on several coagulation and ®brinolytic factors and an indicator of platelet activation. Although the total intake of ®ber was doubled and that of unsoluble ®ber tripled during the rye bread period, the results show hardly any differences between rye bread and wheat bread.
The results cannot be explained by changes in dietary habits. Besides planned differences in the amount and type of ®ber, and the intakes of PUFA and alcohol by women, the diet of the subjects remained unchanged. Intake of PUFA by women was lower and that of alcohol higher during the wheat bread diet. It is highly unprobable that these changes would have masked possible effects of the ®ber.
To our knowledge, the effects of rye on hemostatic factors have not been reported. In a cross-sectional Finnish study the intake of rye (but not ®ber) was inversely associated with plasma FVIIc in young subjects (15 ± 30 y; Mutanen et al, 1995) , suggesting that the effective component in rye could be something other than ®ber, e.g. phytochemicals present in rye. Cereal ®ber intake in general was also inversely associated with plasma ®brinogen in middle-aged men (Fehily et al, 1982) .
Most reported studies have, however, not made a distinction between the types of ®ber. Reduced PAI levels, indicating increased ®brinolytic activity, have been associated with a high intake of total ®ber (Boman et al, 1994) and with a high intake of fruit and vegetables (Nilsson et al, 1990) . Carbohydrate intake, especially starch and ®ber intake, was inversely associated with PAI-1, tPA, FVIIc and factor X in middle-aged men (Rankinen et al, 1994) . On the other hand, in the Caerphilly study an inverse (although weak) association between ®ber and antithrombin III (AT III), the major inhibitor of blood coagulation, was seen (Rogers et al, 1988) . FVII was inversely associated with ®ber intake in elderly Dutch subjects (Mennen et al, 1997) . Differences in the effects of ®bre were seen between the genotypes of RaQ353 polymorphism, with the RR genotype showing the strongest association (Mennen et al, 1998) .
Experimental studies generally support epidemiological ®ndings. In general, an inverse association between ®ber intake and FVIIc has been reported (Simpson et al, 1982; Marckmann et al, 1993b ). An extremely high-®ber diet (95 g ®beraday), mainly from leguminous vegetables, caused a signi®cant decrease in FVIIc, but not in ®brino-gen, in diabetic subjects (Simpson et al, 1982) . A study on the acute effects of ®ber however, indicated, no effect on FVII levels of meals varying in ®ber content (2±4 gaMJ; Marckmann et al, 1993a . It has been suggested that the effect of ®ber on FVII may be mediated through triglyceride (TG) rich lipoproteins. TG-rich lipoproteins might affect either the extent of FVII activation or FVII protein catabolism. In the present study there were no signi®cant differences in serum tyriglycerides between the bread periods. Through reducing absorption of sterols, ®ber may also cause altered serum concentrations of hormones. Hormones (oral contraceptives and postmenopausal hormone replacement therapy), in turn, have been shown to affect FVIIc (Folsom et al, 1991) .
Fibrinolytic activity was already increased in young men after a low-fat (26 energy%)ahigh-®ber (4.5 gaMJ) diet after 2 weeks (Marckmann et al, 1993b) and was sustained for 8 months (Marckmann et al, 1994 ). An extremely lowfat (10 energy%)ahigh-®ber (35±45 ga1000kcal) diet for 3 weeks signi®cantly reduced plasma tPA and PAI-1 as well as plasminogen (Mehrabian et al, 1990) , but the effect may be at least partly attributable to the reduced fat intake. The diet of our subjects was also rather low in fat and remained so throughout the study, but the intake of ®ber was signi®cantly lower than that in the studies of Marckmann et al, 1993b Marckmann et al, , 1994 and Mehrabian et al (1990) . (Mutanen & Aro 1997; Turpeinen & Mutanen, 1999) . However, in the study of Mutanen and Aro (1997) a decrease in plasma D-dimmers was seen when switching from the subjects' habitual diet with a PaS ratio (ratio betwen dietary polyunsaturated and saturated fatty acids) of 0.36 to a high dairy fat diet (PaS ratio 0.24). Although a difference of marginal signi®cance was also found in the present study between the diet periods, the reduction observed (248 vs 205 ngamL) probably has no physiological signi®cance.
Data from previous studies thus suggests in general a bene®cian effect for ®ber on hemostasis via decreased coagulation and enhanced ®brinolysis. Also, the lack of information on the types of ®ber consumed does not allow further conclusions on effects of different types of ®ber. The bene®cial effects of ®ber on lipoproteins are attributed to soluble ®ber. Whether the same holds true for hemostasis is unknown, but it could offer an explanation for our results: although the intake of insoluble ®ber was tripled (on average 220% increase), that of soluble ®ber increased only by 65% (from 4.2 to 6.7 g in men and from 3.5 to 6.0 g in women). Also, in most studies showing signi®cant effects of ®ber, intakes of ®ber have been markedly higher than in our study.
Platelets also play a signi®cant role in hemostasis. Reported effects of dietary ®ber on platelet function are limited to two controlled, but small-scale interventions on the effects of pectin and wheat bran as well as white and wholemeal bread on platelet aggregation, blood clot lysis time and bleeding time (Challen et al, 1983) . The results showed no effect for dietary ®ber on platelet function (Challen et al, 1983) . We measured the urinary excretion of thromboxane metabolites, seen to re¯ect platelet thromboxane A 2 production during platelet activation. In line with previous studies (Wennmalm et al, 1991; Nowak et al, 1987; Barrow et al, 1989) , a trend for increased excretion was seen in smokers, whereas the wheat bread and rye bread diets did not differ. Although we could ®nd no differences between the two bread periods, dietary factors, namely dietary fatty acid composition, has been shown to affect excretion of thromboxane metabolites in several studies (Ferretti et al, 1993; Prakash et al, 1994 , Turpeinen et al, 1998a .
Thus it seems that the effects of individual nutrients may be limited and the effect mediated rather via the interaction between nutrients. The strongest effects have been seen when a diet has been high in ®ber and also low in fat whereas, in line with our results, no effect on coagulation and ®brinolysis was noted when using mixed natural diets differing only in their ®ber contents (Marckmann et al, 1993a) .
